Digitalis-induced "centro-chilar" (possibly a typographical error meant to reference "ventricular") tachycardia refers to an arrhythmia precipitated by digitalis toxicity. The appropriate treatment option for such tachycardia involves the administration of a drug that can effectively counteract the arrhythmic effects of digitalis. Among the options presented:
- Lidocaine
- Reducing dosage of digoxin itself, reverses the condition
- Verapamil
- Beta blockers
Lidocaine is the most suitable treatment. It is a class IB antiarrhythmic that acts preferentially on ischemic or depolarized Purkinje and ventricular tissue by blocking sodium channels, thereby reducing the automaticity and stabilizing the cardiac rhythm.
Here's a step-by-step explanation:
- Lidocaine is especially useful for ventricular arrhythmias associated with digitalis toxicity because it can decrease the heightened automaticity that digoxin may induce in the ventricular myocardium.
- Other options like verapamil and beta-blockers can exacerbate heart block or lead to further complications due to their effects on cardiac contractility and conduction through the AV node.
- Reducing the dosage of digoxin is a general management strategy but does not directly suppress the acute arrhythmic event as lidocaine does.
Therefore, for the management of tachycardia associated with digitalis, lidocaine provides immediate antiarrhythmic action.